| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $36.4M | — | +20.1% |
| Cost of Revenue | $20.8M | — | +49.8% |
| Gross Profit | $15.6M | — | -5.2% |
| R&D Expense | $7.3M | — | -27.0% |
| SG&A Expense | $29.8M | — | -8.3% |
| Operating Income | -$41.4M | — | -56.9% |
| Pre-tax Income | -$17.5M | — | +25.1% |
| Income Tax | -$7K | — | +99.8% |
| Net Income | -$17.5M | — | +14.5% |
| EPS (Basic) | -$0.37 | — | +30.2% |
| EPS (Diluted) | -$0.37 | — | +30.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.2M | +21.3% | -52.7% |
| Accounts Receivable | $26.8M | -10.7% | -5.2% |
| Inventory | $51.0M | -6.9% | +64.2% |
| Current Assets | $185.7M | -12.5% | -44.6% |
| Total Assets | $366.7M | -12.4% | -7.5% |
| Current Liabilities | $49.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.1M | — | -30.4% |
| Capital Expenditures | $87K | — | -93.1% |
| Investing Cash Flow | $25.3M | — | -22.9% |
| Financing Cash Flow | -$770K | — | -928.0% |
| Free Cash Flow | -$18.2M | — | -20.1% |
| +23.5% |
| Total Liabilities | $84.5M | -31.3% | +5.5% |
| Stockholders' Equity | $282.1M | -4.6% | -10.8% |